Malaysia

Former Goldman colleagues to face off in 1MDB graft trial 

Prosecutors set to call in Tim Leissner as key witness in trial of Roger Ng

Updated 4 years ago · Published on 16 Feb 2022 6:47PM

Former Goldman colleagues to face off in 1MDB graft trial 
Roger Ng, former head of investment banking in Malaysia for the global financial services company, is charged with conspiring to launder money and violate an anti-bribery law. – headtopics.com pic, February 16, 2022

KUALA LUMPUR – The trial over the plundering of millions of dollars from Malaysia’s 1MDB sovereign wealth fund continues with two former Goldman Sachs colleagues set to go against each other in a courtroom in Brooklyn, New York today. 

Roger Ng, former head of investment banking in Malaysia for the global financial services company, is charged with conspiring to launder money and violate an anti-bribery law.

Prosecutors are set to call in Tim Leissner, Ng’s former boss at the bank’s Southeast Asia branch, as their key witness. 

During the opening statements at Ng’s trial on Monday in the Brooklyn federal court, prosecutors alleged that he had received millions in compensation for aiding the embezzlement of funds from 1MDB, reported Reuters. 

In 2018, Leissner had pleaded guilty to money laundering and bribery charges, further agreeing to cooperate with the government’s examination into the case. 

Ng, however, has pleaded not guilty.

Defence lawyer Marc Agnifilo said in his opening statement that Ng had no part in the plan allegedly executed by Leissner together with Malaysian businessman Low Taek Jho, also known as Jho Low, who acted as a middleman for deals where Goldman helped 1MDB sell US$6.5 million in bonds. 

Low was indicted in the United States alongside Ng in 2018. The accused mastermind behind the scheme has not been arrested by either US or Malaysian authorities. 

Reuters reported that Low’s lawyers did not respond to a request for comment. 

According to the new agency, US prosecutors claim that Goldman earned US$600 million in payment from the deals, and that roughly US$4.5 billion of the funds raised were embezzled.

Since then, Goldman has paid a nearly US$3 billion fine and also arranged for its Malaysian subsidiary to plead guilty in a US court. 

Leissner’s testimony is expected to start at 10.30pm (Malaysian time) today. – The Vibes, February 16, 2022

Related News

Malaysia / 3h

Najib raises objections to 80% of ex-1MDB CEO’s witness statement over hearsay

Malaysia / 1d

US$620 million returned, not to Najib's account - Angela

Malaysia / 6d

1MDB audit did not cover Najib’s personal accounts, court told

Malaysia / 1w

Shafee seeks to strike out parts of Tony Pua's statement

Malaysia / 1w

Najib must be held accountable for 1MDB's US$5.6 billion loss -  lawyer

Opinion / 2w

BN, you can’t have your cake and eat it too

Spotlight

Malaysia

Najib raises objections to 80% of ex-1MDB CEO’s witness statement over hearsay

Malaysia

Tun Dr Mahathir, Siti Hasmah create ASEAN record

By Alfian Z.M. Tahir

Malaysia

Nanta Linggi to leave Parliament after five terms, may contest new Sarawak state seat

World

Typhoon Dolphin’s remnants swamp Beijing as China braces for more extreme rainfall

Malaysia

Anwar expected to leave hospital today after successful treatment

Malaysia

Husband and wife face death penalty for drug trafficking

Malaysia

Former Subang MP, Wong Chen joins Bersama

Malaysia

Malaysian dies while transiting in Bangkok to Japan (video)

You may be interested

Malaysia

Is reputation worth so much more than a person’s life?

Malaysia

RoS probes Bersatu complaint over position in Perikatan Nasional

Malaysia

Thai officer involved in mid-air disturbance on Malaysia-Bangkok flight (video)

Malaysia

US$620 million returned, not to Najib's account - Angela

Malaysia

Man, 49, found dead in Banting plantation

Malaysia

Malaysian held in Chennai after 4kg of high-grade hydroponic cannabis seized

Malaysia

Speaker informs EC of Subang parliamentary seat vacancy

Malaysia

Anwar expected to leave hospital today after successful treatment